Gemcitabine, carboplatin, and Epstein–Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial
Titel:
Gemcitabine, carboplatin, and Epstein–Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial
Auteur:
Toh, H.C. Yang, M.-H. Wang, H.-M. Hsieh, C.Y. Chitapanarux, I. Ho, K.F. Hong, R.-L. Ang, M.K. Colevas, A.D. Sirachainan, E. Lertbutsayanukul, C. Ho, G.F. Nadler, E. Algazi, A. Lulla, P. Wirth, L.J. Wirasorn, K. Liu, Y.C. Ang, S.F. Low, S.H.J. Tho, L.M. Hasbullah, H.H. Brenner, M.K. Wang, W.-W. Ong, W.S. Tan, S.H. Horak, I. Ding, C. Myo, A. Samol, J.